Delivery Order SPE2DB20D7059-SPE2DB25FQHP6
- Not listed
- The Defense Logistics Agency has awarded a delivery order valued at $1,362.40 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram units. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of September 29, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,119.18 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram unit on September 24, 2025, with an ultimate completion date of September 25, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The award was performed at the awardee's Corporate Office location in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's headquarters. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,276.46 to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% Foam in 10-gram units. This non-set-aside, competitively awarded contract operates under a firm fixed price structure with a completion date of July 25, 2025. The delivery order was issued on July 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a $2,224.94 delivery order to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram units under a firm fixed-price contract type with no set-aside designation. The order was awarded on September 26, 2025, with an ultimate completion date of September 29, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,141.16 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram unit on April 22, 2025, with an ultimate completion date of April 23, 2025. This competitive, non-set-aside award utilizes firm fixed-price pricing and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a $5,030.40 firm fixed price delivery order to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram quantities, with an ultimate completion date of August 14, 2025. This non-set-aside competitive award represents a child order under AmerisourceBergen's larger pharmaceutical supply contract vehicle with DLA. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company serves as a critical...
- The Defense Logistics Agency awarded a $2,096.00 delivery order to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram quantities under a firm fixed-price contract with an ultimate completion date of August 18, 2025. This is a non-set-aside award issued competitively and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a $1,077.91 delivery order to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% Foam in a 10-gram quantity, with an ultimate completion date of May 7, 2025. This is a firm fixed price, non-set-aside delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product is being delivered to Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $1,228.60 to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Proctofoam-HC 1%-1% foam in 10-gram units. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, scheduled for completion by July 11, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,681.58 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam, a topical pharmaceutical product in a 10-gram formulation. This non-competitive delivery order, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a firm fixed price contract. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a child...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FQHP6Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,048.10 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% foam (10 gm) on May 30, 2025, with completion scheduled for June 2, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded transaction under DLA's pharmaceutical and medical supply procurement program. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare systems globally. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract vehicle, which encompasses specialty medications, brand-name and generic drugs, vaccines, and other medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 5/30/25 |